Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
Clinical trial NCT03333005 · COMPLETED
Trial details
- NCT number
- NCT03333005
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-10-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.